ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Clinical trials for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New oral drug aims to treat anemia in dialysis patients
Disease control CompletedThis phase 3 study tested an oral drug called MT-6548 (vadadustat) in 24 adults on hemodialysis in Japan who have anemia due to chronic kidney disease. The goal was to see if the drug can raise and keep hemoglobin levels in a healthy range. Participants took the pill and had thei…
Matched conditions: ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New anemia pill challenges standard shot for dialysis patients
Disease control CompletedThis study tested a new drug called MT-6548 against a standard treatment (darbepoetin alfa) for anemia in people on dialysis for chronic kidney disease. About 323 participants in Japan received either the new drug or the standard one to see if it worked as well at keeping hemoglo…
Matched conditions: ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC